Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2007-006051-39-DE
EUCTR2007-006051-39-DE
Active, not recruiting
Not Applicable

Pharmakokinetic investigation on the tissue penetration of moxifloxacin within the pericardial space

Philipps Universität Marburg0 sites15 target enrollmentFebruary 16, 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPatients with chronic pericardial effusion , 5 of them with pericardial effusion indiced by malignancies, 10 of them with chronic inflammatory pericardial effusionMedDRA version: 9.1Level: PTClassification code 10034474Term: Pericardial effusion
DrugsAvalox

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Patients with chronic pericardial effusion , 5 of them with pericardial effusion indiced by malignancies, 10 of them with chronic inflammatory pericardial effusion
Sponsor
Philipps Universität Marburg
Enrollment
15
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 16, 2009
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Key inclusion criteria: age between 18\-85y, presence of a moderate or large pericardial effusion (Horowitz c or D class) due to malignancies or chronic inflammatory pericarditis
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Key exclusion criteria: acute pericardial effusion or ecpected life time \< 5 days, known flourochinolon allergy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Withdrawn
Phase 4
Evaluation of the intracellular pharmacokinetics of decitabine in patients with leukemia or myelodysplasia
NL-OMON46533niversitair Medisch Centrum Groningen6
Recruiting
Not Applicable
Bioequivalence Study of Somatropin in Healthy Human Volunteers..
IRCT20130626013776N20AryaTinaGene Biopharmaceutical Co30
Completed
Not Applicable
Bioequivalence Study of Pegfilgrastim in Healthy Human Volunteers
IRCT20130626013776N8AryaTinaGene Biopharmaceutical Co24
Completed
Not Applicable
Bioequivalence Study of Filgrastim in Healthy Human VolunteersHealthy volunteers.
IRCT20130626013776N7AryaTinaGene Biopharmaceutical Co24
Completed
Phase 1
Pharmacokinetics of intralesional EGF in patients with diabetic foot ulcers.Diabetic foot ulcer, Wagner grades 1 or 2Diabetic FootFoot UlcerLeg UlcerSkin UlcerDiabetic AngiopathiesVascular DiseasesDiabetes ComplicationsDiabetic NeuropathiesDiabetes MellitusEndocrine System DiseasesCardiovascular Diseases
RPCEC00000047Center for Genetic Engineering and Biotechnology (CIGB), Havana.16